Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
Br J Dermatol, 2020.
Mahil SK, Wilson N, Dand N, Reynolds NJ, Griffiths CEM, Emsley R, Marsden A, Evans I, Warren RB, Stocken D, Barker JN; Burden AD, Smith CH; BADBIR study group and the PSORT consortium.
Read publication: Br J Dermatol
Related
Characteristics of "super responders" and "super nonresponders" to first biologic monotherapy for ps...
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoria...
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the Br...
0 Comments